Results 201 to 210 of about 32,977 (261)

From Pharmaceutical to Biophysical Therapies: New Horizons in Inflammatory Bowel Disease Management

open access: yesJCC Plus, Volume 1, Issue 2, March 2026.
Important limitations exist in the current pharmacological landscape of Inflammatory Bowel Disease (IBD), such as variable response rates and treatment‐limiting adverse effects. In this review, we perform a critical assessment of the current literature on novel multimodal biophysical approaches showing alternative mechanisms of action to, and potential
Benedetta Ricchi   +7 more
wiley   +1 more source

Frequency‐ and Layer‐Specific Modulation of Cortical Neuronal Activity by Pulsed Electrical Stimulation

open access: yesMedComm, Volume 7, Issue 3, March 2026.
High‐frequency electrical stimulation induces stronger activation in excitatory neurons, while both frequencies enhanced similar activation in inhibitory neurons. Both frequencies modulate neuronal rhythm and coherence in excitatory and inhibitory neurons similarly.
Xinzhi Ye   +9 more
wiley   +1 more source

Movement Disorders in Neuromyelitis Optica Spectrum Disorder: A Systematic Review

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 3, Page 600-610, March 2026.
Abstract Background Several movement disorders (MD) have been reported to occur in neuromyelitis optica spectrum disorder (NMOSD). No extensive review has addressed the whole spectrum of MD in NMOSD. Objective This article aims to review MD in NMOSD, describing its prevalence and features.
Luciana A.F. Bringel   +18 more
wiley   +1 more source

Is Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 3, Page 683-691, March 2026.
Abstract Background Dysphagia remains a major clinical concern in multiple system atrophy (MSA), and so far, lacks relevant treatment options. Objective To systematically assess levodopa‐responsiveness of dysphagia in MSA. Methods 19 MSA‐patients underwent endoscopic swallowing evaluation in Off‐ and On‐state, following an adapted FEES‐levodopa‐test ...
Florin Gandor   +10 more
wiley   +1 more source

Anticholinergic Burden and Botulinum Toxin Needs after Deep Brain Stimulation in Adult and Pediatric Patients with Dystonia

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 3, Page 774-778, March 2026.
Abstract Background Anticholinergic medications and botulinum neurotoxin injections are established treatments for dystonia, yet they carry potential side effects and practical challenges. Deep brain stimulation (DBS) is offered in case of poor response to these approaches.
Marcela A. Montiel   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy